SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a company developing innovative new therapies directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced it will present a corporate overview at Citi’s 15th Annual BioPharma Virtual Conference.
Date: Tuesday, September 8th
Time: 4:40 p.m. EDT
Presenter: Zachary Hornby, President and Chief Executive Officer of Boundless Bio
About Boundless Bio
Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.
For more information, visit www.boundlessbio.com.
Follow us on LinkedIn and Twitter.
